Verano Holdings (VRNO) Total Liabilities (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Total Liabilities of $1.0 billion for Q1 2026, down 0.55% year-over-year from $1.0 billion in Q1 2025, and down 1.68% quarter-over-quarter from $1.0 billion in Q4 2025.
Verano Holdings (VRNO) Total Liabilities (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Total Liabilities for 6 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 0.55% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (down 0.55% YoY), while the FY2025 annual figure was $1.0 billion, changed 0.39% from the prior year.
- Total Liabilities slipped to $1.0 billion in Q1 2026 per VRNO's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $1.1 billion in Q3 2024 and bottomed at $1.0 billion in Q2 2025.
- Historically, Total Liabilities has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
- Annual changes were most pronounced in 2024 — Total Liabilities grew 5.31% — and 2025, when it decreased 5.08%.
- Verano Holdings' Total Liabilities stood at $1.1 billion in 2022, then rose by 2.29% to $1.1 billion in 2023, then slipped by 3.28% to $1.0 billion in 2024, then fell by 0.39% to $1.0 billion in 2025, then slipped by 1.68% to $1.0 billion in 2026.
- Business Quant data shows VRNO's Total Liabilities at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | 1.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.08 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Dec 31, 2021 | 1.07 Bn |